Muscle electrical stimulation and nutrition therapy in gastrointestinal cancer patients
Tests electrical muscle stimulation with nutrition therapy in adults with gastrointestinal cancers.
Plain-language title generated from the registry record
Registry title: Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients
Key facts
- Where
- Cologne, GermanySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with oesophageal, stomach, duodenal, colon or rectal cancer after surgery. It tests whole-body muscle stimulation with nutritional therapy.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Oesophageal, gastric, duodenal, colon or rectal cancer after surgery
- Earlier treatment
- Surgery, either with no further therapy or with neoadjuvant and adjuvant therapy
Main reasons for not taking part
- Pacemaker, pump, coronary stent or other metal or electronic implants
- Pregnancy
- Epilepsy or cardiac arrhythmia
- Untreated high blood pressure
- Taking part in another exercise or nutrition study
Read by machine on 9 November 2026.
Where in Germany
- Universitätsklinikum Köln, Centrum für Integrierte Onkologie (CIO)Cologne, GermanyContact: Helen SchörghoferNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Cologne
- Trial code
- NCT06414122
- Record updated
- 27 July 2026
- Original description
The purpose of this study is to assess the efficacy of modulated mid-frequency whole-body electromyostimulation (WB-EMS) combined with nutritional therapy in patients with gastrointestinal cancer.Read full original descriptionShow less
The Efficacy of Modulated Mid-frequency (Whole-body Electromyostimulation) and Nutritional Therapy in Patients With Solid Tumors of the Gastrointestinal Tract (Excluding Liver and Pancreatic Carcinomas)
The purpose of this study is to assess the efficacy of modulated mid-frequency whole-body electromyostimulation (WB-EMS) combined with nutritional therapy in patients with gastrointestinal cancer.
Inclusion: Patients with oesophageal, gastric, duodenal, colon or rectal cancer following surgery without further therapy and with neoadjuvant and adjuvant therapy; medical clearance for exercise training; written declaration of consent from the study participant.
Exclusion: Electronic implants such as pacemakers, pumps, and coronary stents; Implants in the area of application (e.g. breast implants); Metal and electronic parts in the body (e.g. prostheses, metal vascular clips, hearing aids/inner ear/cochlear implants, magnetic dental prostheses, pacemakers, contraceptives); Cardiac arrhythmia; Epilepsy; Wounds and open skin diseases in the area of application of the electrodes; Acute inflammatory diseases (e.g. inflammation of the intervertebral discs, bones, vessels, or soft tissue); Bone diseases with high-grade osteoporosis; Increased risk of haemorrhage; Fever and illnesses that can be aggravated by physical exertion; Participation in another study on the topic of exercise or nutrition; Pregnancy; Unhealed operations or bone fractures; Directly after herniated discs or other instabilities such as large abdominal wall hernias; Blood clots (thromboses); Untreated high blood pressure; Blindness; Continuous parenteral nutrition.